{"id":"https://openalex.org/W2045429520","doi":"https://doi.org/10.5414/cpp49046","title":"Toxic dermatitis in patients treated with Taxotere\u00ae (docetaxel): three case reports","display_name":"Toxic dermatitis in patients treated with Taxotere\u00ae (docetaxel): three case reports","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2045429520","doi":"https://doi.org/10.5414/cpp49046","mag":"2045429520","pmid":"https://pubmed.ncbi.nlm.nih.gov/21176725"},"language":"en","primary_location":{"id":"doi:10.5414/cpp49046","doi":"https://doi.org/10.5414/cpp49046","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp49046","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063189238","display_name":"Brigit P. C. van Oijen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B. van Oijen","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Orbis Medical Center, Sittard, The Netherlands. b.vanoijen@orbisconcern.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Orbis Medical Center, Sittard, The Netherlands. b.vanoijen@orbisconcern.nl","institution_ids":["https://openalex.org/I4210133559"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019709986","display_name":"M. Pleunis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Pleunis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111777532","display_name":"F. Erdkamp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Erdkamp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038883974","display_name":"Ruud L.M.A. Prevoo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Prevoo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051307639","display_name":"P.H.M. van der Kuy","orcid":"https://orcid.org/0000-0002-7128-8801","observed_orcids":["https://orcid.org/0000-0002-7128-8801"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. van der Kuy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3828,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.6468563,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"49","issue":"01","first_page":"46","last_page":"48"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/toxic-dermatitis","display_name":"toxic dermatitis","score":0.9390000104904175},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9760000109672546},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.765999972820282},{"id":"https://openalex.org/keywords/chemotherapy-induced-skin-toxicity","display_name":"chemotherapy-induced skin toxicity","score":0.5839999914169312},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9809129238128662},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7233384847640991},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5949528217315674},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4705643653869629},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3554528057575226},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3458091616630554}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.5414/cpp49046","doi":"https://doi.org/10.5414/cpp49046","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp49046","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:21176725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21176725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2470524101","https://openalex.org/W115947862","https://openalex.org/W1550862849","https://openalex.org/W2188127770","https://openalex.org/W2161405993","https://openalex.org/W4403583790","https://openalex.org/W2104909849","https://openalex.org/W2406108149","https://openalex.org/W2032914120","https://openalex.org/W1782806116"],"abstract_inverted_index":{"Three":[0],"out":[1],"of":[2,19],"25":[3],"patients":[4,28],"receiving":[5],"the":[6,44],"same":[7],"batch":[8],"docetaxel,":[9],"developed":[10],"toxic":[11,45],"dermatitis":[12],"within":[13],"5":[14],"days":[15],"after":[16],"administration.":[17],"Timing":[18],"occurrence":[20],"was":[21],"equal":[22],"and":[23],"symptoms":[24],"were":[25],"similar.":[26],"Two":[27],"continued":[29],"with":[30],"docetaxel":[31],"without":[32],"any":[33],"problems.":[34],"There":[35],"is":[36],"no":[37],"assignable":[38],"cause":[39],"found":[40],"that":[41],"could":[42],"explain":[43],"dermatitis.":[46]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}